Wikipedia -WSS

Wikipedia

author：focus 2025-10-01 23:06:09 - browse：833

Apellis Pharmaceuticals said Tuesday that it had identified “internal structural variations” in a type of needle used by doctors to prepare syringes of its eye disease drug Syfovre as a possible cause of severe eye inflammation reported in patients receiving the treatment — but the company stopped short of definitively linking the needle to the cases.

Additionally, Apellis confirmed one additional case of the severe and potentially blinding side effect, known as retinal occlusive vasculitis, or ROV, that occurred in May. But with thousands of more Syfovre eye injections also performed, the overall frequency of ROV remains unchanged and rare, even with the added scrutiny and increased physician monitoring.

Apellis shares rose 30% to $40 in Wednesday’s pre-market trading on the growing belief amongst investors that Syfovre’s safety crisis is abating.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Addiction experts warn against a second 'war on drugs'

leisure time

WSS

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Data integrity in scientific journals requires "effort" by publishers, institutions

NVIDIA and Google execs on the future of AI and drug discovery

Stanford updates investigation of president’s past research

Readout LOUD podcast: Live from STAT Breakthrough Summit West

It's time to retire 'poor historian' from clinicians' vocabularies

hotspot

Wikipedia

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

Researchers separate signal from noise in heart wearable data

Hepatitis C has a cure — but many Americans still lack access to it

Stanford president to resign after investigation of research

Affirmative action in medical school literally saved lives

Medical experts are missing from AI regulatory conversations

Novavax promises a turnaround & Lilly roils the obesity market

DOJ, FTC to increase scrutiny of all types of health care mergers

Medicare details structure of new drug price negotiation program

Big Tobacco's 'harm reduction': Is it for real, or a sham?

focus

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Cytokinetics CEO stresses company can launch heart drug on its own

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

New warning issued for rebooking air travel after delays, cancellations

Lindsay Lohan welcomes 1st child with husband Bader Shammas

hotspot

leisure time

leisure time

entertainment